However the success of this method is constrained by strong background signal from the amplified wild-type (wt) EGFR allele, requiring a minimum acceptable tumour cell content of 50 % and high quality DNA, thus affecting its practical usefulness in NSCLC clinics [3, 4]. Here, EGFR is linked to neoplasm.